Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1051-1060 of 3427 for cancer

Edit search filters
  1. Gemcitabine Hydrochloride in Treating Patients with Locally Advanced Pancreatic Cancer

  2. A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

    Rochester, MN

  3. Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL

    Scottsdale/Phoenix, AZ

  4. Study of Cryoablation for Metastatic Lung Tumors

    Rochester, MN

  5. Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

    Jacksonville, FL

  6. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study to Evaluate Binimetinib in Combination with Encorafenib in Patients with Pancreatic Malignancies and a Somatic BRAFV600E Mutation

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. T-DM1 vs Paclitaxel/Trastuzumab for Breast

    Rochester, MN

  9. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia

  10. A Study of the Combination of IMCgp100 with Durvalumab and/or Tremelimumab for Patients with Advanced Cutaneous Melanoma

.

Mayo Clinic Footer